[Treatment of ischemic brain lesions].
D001921:Brain / Q000098:blood supply; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D002561:Cerebrovascular Disorders / Q000188:drug therapy* / Q000503:physiopathology; D002859:Chromium Isotopes; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy* / Q000503:physiopathology; D007511:Ischemia / Q000188:drug therapy / Q000503:physiopathology; D002546:Ischemic Attack, Transient / Q000188:drug therapy; D008134:Long-Term Care; D008722:Methods; D013997:Time Factors; D014665:Vasodilator Agents / Q000494:pharmacology / Q000627:therapeutic use*
D002859:Chromium Isotopes; D014665:Vasodilator Agents
Zur Behandlung der ischämischen Hirnschädigung.